Current Portfolio
Nouscom
Next-generation neo-epitope vaccines and oncolytic viruses.
Key Facts
- Sector
Life Sciences
- Country
Switzerland
- Fund
LSP 5
- Entry
2015
Website
Do You Want to Know More?
We are eager to explore how we can achieve great things together.